CLOSE X
Mutual Fund
more from Mutual Fund
HomeMarketsMutual Fund MF UpdatesFund Card

Fund Card

GO

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)

very highequitypharma & health care
26.26 0.29(1.12%) NAV as on 25 Apr 2024
0.77 % 1 M
55.94 % 1 Y
14.73 % 3 Y

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • max

FUND OBJECTIVE

Investment objective of the scheme is to provide long term capital appreciation by investing in equity & equity related instruments of the companies in the Pharmaceuticals, Healthcare and Allied sectors in India.The Scheme does not guarantee/indicate any returns. There can be no assurance that the schemes objectives will be achieved.

SCHEME DETAILS

expense_ration-icon Expenses Ratio :

2.37

As on 31 Mar, 2024
age-icon Age :

4 yrs 9 m

Since 10 07 ,2019
exit_load Exit Load :

1%

aum AUM :

699.55 Crs

lock_in Lock-in :

1% on or before 30D, Nil after 30D

investing_style Investing Style :

Large Growth

Portfolio_book_value Portfolio Price To Book Value :

7.38

Min_Investment Min. Investment :

SIP 100 & Lumpsum 1000

Scheme_benchmark Scheme Benchmark :

S&P BSE HEALTH CARE - TRI

Fund_manager Fund Manager :

Dhaval Shah

LATEST ASSET & PORTFOLIO ALLOCATION

as on Mar 31 ,2024
Others 6.96 %
Equity 93.04 %

TOP HOLDINGS

Sun Pharmaceutical Industries...15.74 %
Cipla Ltd.8.31 %
Torrent Pharmaceuticals Ltd.7.24 %
Apollo Hospitals Enterprise Ltd.6.72 %
Zydus Lifesciences Ltd.4.46 %
See All Holding

ALLOCATION BY MARKET CAP

ALLOCATION BY SECTOR

Pharmaceuticals & Drugs74.35
Hospital & Healthcare Services15.35
Insurance1.90
Business Support1.04
Chemicals0.40
See All Sectors

5-YEARS HISTORY

Financial Year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)9.9916.1218.2216.3626.45
Net Assets(Rs Crores) (as on 31-Mar-2024) 170.68 454.91 515.33 428.44 699.55
Scheme Returns(%)(Absolute)-0.1063.4912.40-10.2661.38
B'mark Returns(%)(Absolute)NANANANANA
Category Rank6/7555/7549/7570/7611/90

RISKOMETER Level of Risk in the Scheme

Investors understand that their principal will be at very high risk

PERFORMANCE COMPARISON WITH SIMILAR SCHEMES

Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Very HighEquity26.260.29(1.12%)NAV As on 25 Apr, 202410-Jul-2019Inception Date699.55AUM In Cr.55.94%1Y14.73%3YNA%5Y22.29%Since Inception
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Very HighEquity30.660.36(1.19%)NAV As on 25 Apr, 202413-Jul-2018Inception Date3,772.32AUM In Cr.58.94%1Y17.88%3Y24.49%5Y21.35%Since Inception
SBI Healthcare Opp Fund-Reg(G)Very HighEquity344.410.76(0.22%)NAV As on 25 Apr, 202414-Jul-1999Inception Date2,626.34AUM In Cr.54.50%1Y17.80%3Y23.16%5Y16.11%Since Inception
DSP Healthcare Fund-Reg(G)Very HighEquity32.450.23(0.73%)NAV As on 25 Apr, 202430-Nov-2018Inception Date2,352.32AUM In Cr.51.82%1Y16.49%3Y25.51%5Y24.33%Since Inception
Tata India Pharma & Healthcare Fund-Reg(G)Very HighEquity25.050.29(1.19%)NAV As on 25 Apr, 202428-Dec-2015Inception Date878.70AUM In Cr.53.10%1Y16.35%3Y22.08%5Y11.65%Since Inception
Nippon India Pharma Fund(G)Very HighEquity427.184.56(1.08%)NAV As on 25 Apr, 202405-Jun-2004Inception Date7,125.28AUM In Cr.52.35%1Y16.03%3Y22.67%5Y20.76%Since Inception
corporate OFFICE Jhaveri Securities301/302 Payal Tower-II,Opp. M. S. University, Sayajigunj, Vadodara 390020.
CALL US 91-265-6161200/7161200
EMAIL US info@jhaveritrade.com
SEBI Reg. No. NSE, BSE, MCX : INZ000199232 Membership No.: NSE:08232, BSE:3015, MCX:56465 SEBI Regn.No. of DP : IN-DP-195-2016 (NSDL DPID:IN301991) AMFI: ARN-A3524 CIN of JSL: U67120GJ1992PLC018194 | GST : 24AAACJ4727A2Z4
COMPLIANCE OFFICER OFFICE
ATTENTION INVESTORS NSDL/CDSL KYC Advisory for investors
© CopyRights 2022, Jhaveri Securities All rights reserved.
Designed & Developed by Accord Fintech Pvt Ltd.